Offering innovative solutions with high added value to drug delivery formulation issues.

APTYS is a CRO spin-off of the University of Auvergne in Clermont-Ferrand, specialized in drug delivery. Funded in 2002, the company acquired patents rights on pharmaceutical technologies from the University. Aptys’ focus is contract service.

The core business of APTYS is drug delivery.

Our dosage forms include: TABLETS; INHALATED FORMS; FOAMS; LIQUID FORMS; SEMI-SOLID FORMS; IMPLANTS; MICROSPHERES

finding applications in

OPHTALMOLOGY; DERMATOLOGY; PNEUMOLOGY; GASTROENTEROLOGY; ONCOLOGY; INFECTIOLOGY; PEDIATRICS.

Our services are adapted to various strategies: formulation of new chemical entities and peptides/proteins, reformulation of registered products and development of drug delivery systems. We also offer support services such as: analytical development, in vitro dissolution studies, ICH stability studies and ADME studies (PK/PD).

Download brochure